- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02212093
5 Years Mortality-rate in Patients Treated for Severe Pneumonia in an ICU - a Retrospective Study (pneumonia)
Cause-specific 5 Years Mortality-rate in Patients Treated for Severe Pneumonia in an ICU - a Retrospective Study
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
Patients with severe pneumonia who need treatment in an ICU have a high in-hospital mortality (16-46%). There are few studies which investigate the long-term mortality (> 1year) in patients after discharge from the hospital. There seems to be a higher mortality in this group compared to the general population. The cause(s) of this higher long-term mortality is unclear and few studies have investigated this problem.
We are going to investigate the 5 years mortality rate in this population of patients. We are also going to investigate the cause of death in the patients who are discharged from the hospital alive.
Inclusion criteria: Patients > 18 years. Primary diagnose: pneumonia, and the need of mechanical ventilation for at least 24 hours in an ICU. The patients who arrive at the ICU in Akershus University Hospital in the period from 01.01.1997 to 31.12.2006.
The datas are collected from the patients' journals and the local ICU register. Collecting data: Age, sex, comorbidity, SAPSII, mechanical ventilation time, stay in the ICU, stay in the hospital, ICU mortality, hospital mortality, 5 years mortality, type of pneumonia (bacteriology).
Time of death after discharge is collected from Norwegian National Registry. Cause of death after discharge is collected from Norwegian Institute of Public Health.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Akershus
-
Nordbyhagen, Akershus, Norge, 1478
- Akershus University Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Patients > 18 years. Primary diagnose: pneumonia, and the need of mechanical ventilation for at least 24 hours in an ICU. The patients who arrived the ICU in Akershus University Hospital in the period from 01.01.1997 to 31.12.2006.
Exclusion Criteria:
- Patients < 18 years. Patients with need for mechanical ventilation < 24 hours
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Tidsperspektiver: Tilbagevirkende kraft
Kohorter og interventioner
Gruppe / kohorte |
|---|
|
pneumonia and mechanical ventilation
The data are collected retrospectively from this one group.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
5 years mortality
Tidsramme: 5 years
|
5 years
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
cause of death after discharge from the hospital
Tidsramme: 5 years
|
5 years
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Vegard Dahl, Professor, University Hospital, Akershus
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2013/2338
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Lungebetændelse
-
BioVersys SASBioVersys AGRekrutteringHospital Acquired Bacterial Pneumonia (HABP) | Ventilator Associated Bacterial Pneumonia (VABP) | Acinetobacter Baumannii-calcoaceticus kompleks | Colistin-resistent ABCGeorgien
-
ShionogiAfsluttetHospital Acquired Pneumonia (HAP) | Healthcare-associated Pneumonia (HCAP) | Ventilator Associated Pneumonia (VAP)Israel, Spanien, Forenede Stater, Belgien, Canada, Tjekkiet, Estland, Frankrig, Georgien, Tyskland, Ungarn, Japan, Letland, Filippinerne, Puerto Rico, Den Russiske Føderation, Serbien, Taiwan, Ukraine
-
Capital Medical UniversityChina-Japan Friendship Hospital; Beijing Municipal Health CommissionIkke rekrutterer endnuCommunity Acquired Pneumonia (CAP)Kina
-
University of Maryland, BaltimoreIkke rekrutterer endnuCommunity Acquired Pneumonia (CAP)Forenede Stater
-
Assiut UniversityIkke rekrutterer endnuVAP - Ventilator Associated Pneumonia
-
Ente Ospedaliero Cantonale, BellinzonaAfsluttet
-
Ain Shams UniversityAfsluttetVAP - Ventilator Associated PneumoniaEgypten
-
Erasmus Medical CenterChiesi Farmaceutici S.p.A.AfsluttetVentilator Associated Pneumonia (VAP)Spanien, Holland
-
Andrzej Frycz Modrzewski Krakow UniversityAfsluttetVAP - Ventilator Associated PneumoniaPolen
-
Tanta UniversityAfsluttetMekanisk ventilation | Ventilator Associated Pneumonia (VAP)Egypten